Bronchial Carcinoma, Sleep Apnea Syndrome
Conditions
Keywords
ApneaLink, bronchial carcinoma, sleep apnea screening
Brief summary
In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.
Detailed description
Determination of the SAS- frequence in patients with bronchial carcinoma. The patients will be screened at home for 1 night with the ApneaLink device by ResMed. The apneaLink device is a standard screening tool for sleep apnea in clinical practice.
Interventions
DEVICEsleep apnea screening with ApneaLinkTM
ApneaLink is sleep-screening tool that objectively identifies patients with sleep apnea
Sponsors
RWTH Aachen University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with reasonable suspicion of bronchial carcinoma or histologically proven bronchial carcinoma, which has not been medicated until the study entry and * Patients with sleep apnea who had recently been diagnosed with bronchial carcinoma.
Exclusion criteria
* Pregnancy * other already known malignancies or tumors * Patients with non-invasive artificial respiration due to a chronic respiratory insufficiencies
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| percent of sleep apnea in patients with bronchial carcinoma | two days | The percent of sleep apnea in a cohort of patients with bronchial carcinoma will be evaluated. The duration of the study participation is two days. |
Countries
Germany
Contacts
Primary ContactAngela Habier
Outcome results
None listed